Efficacy and Safety of SH-1028 in Patients With EGFR T790M-Positive NSCLC: A Multicenter, Single-Arm, Open-Label, Phase 2 Trial

作者：Anwen Xiong, Shengxiang Ren, Huaimin Liu, Liyun Miao, Lei Wang, Jianhua Chen, Wěi Li, Runpu Li, Xiang Wang, Zhiwei Lu, Donglin Wang, Xiaohong Wu, Zhihua Liu, Ligang Xing, Yimin Mao, Chunling Liu, Aiping Zeng, Hongrui Niu, Yingying Du, Yuping Sun, Yueyin Pan, Yanping Hu, Xiaodong Zhang, Xueqin Chen, Zhiyong Ma, Na Li, Jianyong Zhang, Min Zhao, Xiaoling Li, Feng Ye, Mingjun Li, Guohua Yu, Xiaomeng Zhang, Jie Min, Dong Cho Han, Jin Li, Caicun Zhou · 发表于：Journal of Thoracic Oncology · 年份：2022 · DOI：10.1016/j.jtho.2022.06.013 · 被引用次数：19 · 研究领域：Lung Cancer Treatments and Mutations、Colorectal Cancer Treatments and Studies、Fibroblast Growth Factor Research